APO Research
Talk to an analyst

APO RESEARCH · REPORT

Vaccine Safety Solutions

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Vaccine Safety Solutions Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchVaccine Safety Solutions Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Vaccine Safety Solutions Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Vaccine Safety Solutions Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Vaccine Safety Solutions Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Vaccine Safety Solutions Market Analysis and Forecast 2026-2032234 pages · $4,950 USD

Market perspective

The global Vaccine Safety Solutions market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Vaccine Safety Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Vaccine Safety Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Vaccine Safety Solutions is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Vaccine Safety Solutions market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Vaccine Safety Solutions market include Thermo Fisher Scientific, PHC Holdings Corporation (Panasonic Healthcare), Haier Biomedical, Helmer Scientific, B Medical Systems, Eppendorf AG, Vestfrost Solutions, Follett LLC and Arctiko A/S, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Vaccine Safety Solutions market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Vaccine Safety Solutions and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Vaccine Safety Solutions revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Vaccine Safety Solutions market.

Vaccine Safety Solutions Segment by Company

Thermo Fisher Scientific

PHC Holdings Corporation (Panasonic Healthcare)

Haier Biomedical

Helmer Scientific

B Medical Systems

Eppendorf AG

Vestfrost Solutions

Follett LLC

Arctiko A/S

So-Low Environmental Equipment Co.

Vaccine Safety Solutions Segment by Type

Equipment

Services

Other

Vaccine Safety Solutions Segment by Application

Healthcare and Hospitals

Veterinary

Other

Vaccine Safety Solutions Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Vaccine Safety Solutions status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Vaccine Safety Solutions key companies, revenue, market share, and recent developments.

3. To split the Vaccine Safety Solutions breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Vaccine Safety Solutions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Vaccine Safety Solutions significant trends, drivers, influence factors in global and regions.

6. To analyze Vaccine Safety Solutions competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Vaccine Safety Solutions market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Vaccine Safety Solutions and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Vaccine Safety Solutions.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Vaccine Safety Solutions industry.

Chapter 3: Detailed analysis of Vaccine Safety Solutions company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Vaccine Safety Solutions in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Vaccine Safety Solutions in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Vaccine Safety Solutions Industry Trends Table 2. Vaccine Safety Solutions Industry Drivers Table 3. Vaccine Safety Solutions Industry Opportunities and Challenges Table 4. Vaccine Safety Solutions Industry Restraints Table 5. Global Vaccine Safety Solutions Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Vaccine Safety Solutions Revenue Share by Company (2021-2026) Table 7. Global Vaccine Safety Solutions Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Vaccine Safety Solutions Key Company Manufacturing Base & Headquarters Table 9. Global Vaccine Safety Solutions Company, Product Type & Application Table 10. Global Vaccine Safety Solutions Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Vaccine Safety Solutions by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Equipment Table 15. Significant Companies of Services Table 16. Significant Companies of Other Table 17. Global Vaccine Safety Solutions Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Vaccine Safety Solutions Sales Value by Type (2021-2026) & (US$ Million) Table 19. Global Vaccine Safety Solutions Sales Value by Type (2027-2032) & (US$ Million) Table 20. Global Vaccine Safety Solutions Sales Value Share by Type (2021-2026) Table 21. Global Vaccine Safety Solutions Sales Value Share by Type (2027-2032) Table 22. Significant Companies of Healthcare and Hospitals Table 23. Significant Companies of Veterinary Table 24. Significant Companies of Other Table 25. Global Vaccine Safety Solutions Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Vaccine Safety Solutions Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Vaccine Safety Solutions Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Vaccine Safety Solutions Sales Value Share by Application (2021-2026) Table 29. Global Vaccine Safety Solutions Sales Value Share by Application (2027-2032) Table 30. Global Vaccine Safety Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Vaccine Safety Solutions Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Vaccine Safety Solutions Sales Value Share by Region (2021-2026) Table 33. Global Vaccine Safety Solutions Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Vaccine Safety Solutions Sales Value Share by Region (2027-2032) Table 35. Global Vaccine Safety Solutions Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Vaccine Safety Solutions Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Vaccine Safety Solutions Sales Value Market Share by Country (2021-2026) Table 38. Global Vaccine Safety Solutions Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Vaccine Safety Solutions Sales Value Market Share by Country (2027-2032) Table 40. Thermo Fisher Scientific Company Information Table 41. Thermo Fisher Scientific Business Overview Table 42. Thermo Fisher Scientific Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Thermo Fisher Scientific Vaccine Safety Solutions Product Portfolio Table 44. Thermo Fisher Scientific Recent Development Table 45. PHC Holdings Corporation (Panasonic Healthcare) Company Information Table 46. PHC Holdings Corporation (Panasonic Healthcare) Business Overview Table 47. PHC Holdings Corporation (Panasonic Healthcare) Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. PHC Holdings Corporation (Panasonic Healthcare) Vaccine Safety Solutions Product Portfolio Table 49. PHC Holdings Corporation (Panasonic Healthcare) Recent Development Table 50. Haier Biomedical Company Information Table 51. Haier Biomedical Business Overview Table 52. Haier Biomedical Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Haier Biomedical Vaccine Safety Solutions Product Portfolio Table 54. Haier Biomedical Recent Development Table 55. Helmer Scientific Company Information Table 56. Helmer Scientific Business Overview Table 57. Helmer Scientific Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Helmer Scientific Vaccine Safety Solutions Product Portfolio Table 59. Helmer Scientific Recent Development Table 60. B Medical Systems Company Information Table 61. B Medical Systems Business Overview Table 62. B Medical Systems Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. B Medical Systems Vaccine Safety Solutions Product Portfolio Table 64. B Medical Systems Recent Development Table 65. Eppendorf AG Company Information Table 66. Eppendorf AG Business Overview Table 67. Eppendorf AG Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Eppendorf AG Vaccine Safety Solutions Product Portfolio Table 69. Eppendorf AG Recent Development Table 70. Vestfrost Solutions Company Information Table 71. Vestfrost Solutions Business Overview Table 72. Vestfrost Solutions Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Vestfrost Solutions Vaccine Safety Solutions Product Portfolio Table 74. Vestfrost Solutions Recent Development Table 75. Follett LLC Company Information Table 76. Follett LLC Business Overview Table 77. Follett LLC Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Follett LLC Vaccine Safety Solutions Product Portfolio Table 79. Follett LLC Recent Development Table 80. Arctiko A/S Company Information Table 81. Arctiko A/S Business Overview Table 82. Arctiko A/S Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Arctiko A/S Vaccine Safety Solutions Product Portfolio Table 84. Arctiko A/S Recent Development Table 85. So-Low Environmental Equipment Co. Company Information Table 86. So-Low Environmental Equipment Co. Business Overview Table 87. So-Low Environmental Equipment Co. Vaccine Safety Solutions Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. So-Low Environmental Equipment Co. Vaccine Safety Solutions Product Portfolio Table 89. So-Low Environmental Equipment Co. Recent Development Table 90. Research Programs/Design for This Report Table 91. Authors List of This Report Table 92. Secondary Sources Table 93. Primary Sources List of Figures Figure 1. Vaccine Safety Solutions Product Image Figure 2. Global Vaccine Safety Solutions Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Vaccine Safety Solutions Market Size (2021-2032) & (US$ Million) Figure 4. Global Vaccine Safety Solutions Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Equipment Image Figure 8. Services Image Figure 9. Other Image Figure 10. Global Vaccine Safety Solutions Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 11. Global Vaccine Safety Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 12. Global Vaccine Safety Solutions Sales Value Share by Type (2021-2032) Figure 13. Healthcare and Hospitals Image Figure 14. Veterinary Image Figure 15. Other Image Figure 16. Global Vaccine Safety Solutions Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Vaccine Safety Solutions Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Vaccine Safety Solutions Sales Value Share by Application (2021-2032) Figure 19. Global Vaccine Safety Solutions Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Vaccine Safety Solutions Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Vaccine Safety Solutions Sales Value (2021-2032) & (US$ Million) Figure 22. North America Vaccine Safety Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Vaccine Safety Solutions Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Vaccine Safety Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Vaccine Safety Solutions Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Vaccine Safety Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Vaccine Safety Solutions Sales Value (2021-2032) & (US$ Million) Figure 28. South America Vaccine Safety Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Vaccine Safety Solutions Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Vaccine Safety Solutions Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Vaccine Safety Solutions Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Equipment
  • Services
  • Other
Applications
  • Healthcare and Hospitals
  • Veterinary
  • Other
Companies covered
  • Thermo Fisher Scientific
  • PHC Holdings Corporation (Panasonic Healthcare)
  • Haier Biomedical
  • Helmer Scientific
  • B Medical Systems
  • Eppendorf AG
  • Vestfrost Solutions
  • Follett LLC
  • Arctiko A/S
  • So-Low Environmental Equipment Co.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Vaccine Safety Solutions Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Vaccine Safety Solutions Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Vaccine Safety Solutions Market Dynamics
  1. 2.1 Vaccine Safety Solutions Industry Trends
  2. 2.2 Vaccine Safety Solutions Industry Drivers
  3. 2.3 Vaccine Safety Solutions Industry Opportunities and Challenges
  4. 2.4 Vaccine Safety Solutions Industry Restraints
3 Vaccine Safety Solutions Market by Company
  1. 3.1 Global Vaccine Safety Solutions Company Revenue Ranking in 2025
  2. 3.2 Global Vaccine Safety Solutions Revenue by Company (2021-2026)
  3. 3.3 Global Vaccine Safety Solutions Company Ranking (2024-2026)
  4. 3.4 Global Vaccine Safety Solutions Company Manufacturing Base and Headquarters
  5. 3.5 Global Vaccine Safety Solutions Company Product Type and Application
  6. 3.6 Global Vaccine Safety Solutions Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Vaccine Safety Solutions Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Vaccine Safety Solutions Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Vaccine Safety Solutions Market by Type
  1. 4.1 Vaccine Safety Solutions Type Introduction
  2. 4.1.1 Equipment
  3. 4.1.2 Services
  4. 4.1.3 Other
  5. 4.2 Global Vaccine Safety Solutions Sales Value by Type
  6. 4.2.1 Global Vaccine Safety Solutions Sales Value by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Vaccine Safety Solutions Sales Value by Type (2021-2032)
  8. 4.2.3 Global Vaccine Safety Solutions Sales Value Share by Type (2021-2032)
5 Vaccine Safety Solutions Market by Application
  1. 5.1 Vaccine Safety Solutions Application Introduction
  2. 5.1.1 Healthcare and Hospitals
  3. 5.1.2 Veterinary
  4. 5.1.3 Other
  5. 5.2 Global Vaccine Safety Solutions Sales Value by Application
  6. 5.2.1 Global Vaccine Safety Solutions Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Vaccine Safety Solutions Sales Value by Application (2021-2032)
  8. 5.2.3 Global Vaccine Safety Solutions Sales Value Share by Application (2021-2032)
6 Vaccine Safety Solutions Regional Value Analysis
  1. 6.1 Global Vaccine Safety Solutions Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Vaccine Safety Solutions Sales Value by Region (2021-2032)
  3. 6.2.1 Global Vaccine Safety Solutions Sales Value by Region: 2021-2026
  4. 6.2.2 Global Vaccine Safety Solutions Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Vaccine Safety Solutions Sales Value (2021-2032)
  7. 6.3.2 North America Vaccine Safety Solutions Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Vaccine Safety Solutions Sales Value (2021-2032)
  10. 6.4.2 Europe Vaccine Safety Solutions Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Vaccine Safety Solutions Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Vaccine Safety Solutions Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Vaccine Safety Solutions Sales Value (2021-2032)
  16. 6.6.2 South America Vaccine Safety Solutions Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Vaccine Safety Solutions Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Vaccine Safety Solutions Sales Value Share by Country, 2025 VS 2032
7 Vaccine Safety Solutions Country-level Value Analysis
  1. 7.1 Global Vaccine Safety Solutions Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Vaccine Safety Solutions Sales Value by Country (2021-2032)
  3. 7.2.1 Global Vaccine Safety Solutions Sales Value by Country (2021-2026)
  4. 7.2.2 Global Vaccine Safety Solutions Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Vaccine Safety Solutions Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Vaccine Safety Solutions Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Vaccine Safety Solutions Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Vaccine Safety Solutions Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 PHC Holdings Corporation (Panasonic Healthcare)
  8. 8.2.1 PHC Holdings Corporation (Panasonic Healthcare) Company Information
  9. 8.2.2 PHC Holdings Corporation (Panasonic Healthcare) Business Overview
  10. 8.2.3 PHC Holdings Corporation (Panasonic Healthcare) Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  11. 8.2.4 PHC Holdings Corporation (Panasonic Healthcare) Vaccine Safety Solutions Product Portfolio
  12. 8.2.5 PHC Holdings Corporation (Panasonic Healthcare) Recent Developments
  13. 8.3 Haier Biomedical
  14. 8.3.1 Haier Biomedical Company Information
  15. 8.3.2 Haier Biomedical Business Overview
  16. 8.3.3 Haier Biomedical Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Haier Biomedical Vaccine Safety Solutions Product Portfolio
  18. 8.3.5 Haier Biomedical Recent Developments
  19. 8.4 Helmer Scientific
  20. 8.4.1 Helmer Scientific Company Information
  21. 8.4.2 Helmer Scientific Business Overview
  22. 8.4.3 Helmer Scientific Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Helmer Scientific Vaccine Safety Solutions Product Portfolio
  24. 8.4.5 Helmer Scientific Recent Developments
  25. 8.5 B Medical Systems
  26. 8.5.1 B Medical Systems Company Information
  27. 8.5.2 B Medical Systems Business Overview
  28. 8.5.3 B Medical Systems Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  29. 8.5.4 B Medical Systems Vaccine Safety Solutions Product Portfolio
  30. 8.5.5 B Medical Systems Recent Developments
  31. 8.6 Eppendorf AG
  32. 8.6.1 Eppendorf AG Company Information
  33. 8.6.2 Eppendorf AG Business Overview
  34. 8.6.3 Eppendorf AG Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eppendorf AG Vaccine Safety Solutions Product Portfolio
  36. 8.6.5 Eppendorf AG Recent Developments
  37. 8.7 Vestfrost Solutions
  38. 8.7.1 Vestfrost Solutions Company Information
  39. 8.7.2 Vestfrost Solutions Business Overview
  40. 8.7.3 Vestfrost Solutions Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Vestfrost Solutions Vaccine Safety Solutions Product Portfolio
  42. 8.7.5 Vestfrost Solutions Recent Developments
  43. 8.8 Follett LLC
  44. 8.8.1 Follett LLC Company Information
  45. 8.8.2 Follett LLC Business Overview
  46. 8.8.3 Follett LLC Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Follett LLC Vaccine Safety Solutions Product Portfolio
  48. 8.8.5 Follett LLC Recent Developments
  49. 8.9 Arctiko A/S
  50. 8.9.1 Arctiko A/S Company Information
  51. 8.9.2 Arctiko A/S Business Overview
  52. 8.9.3 Arctiko A/S Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Arctiko A/S Vaccine Safety Solutions Product Portfolio
  54. 8.9.5 Arctiko A/S Recent Developments
  55. 8.10 So-Low Environmental Equipment Co.
  56. 8.10.1 So-Low Environmental Equipment Co. Company Information
  57. 8.10.2 So-Low Environmental Equipment Co. Business Overview
  58. 8.10.3 So-Low Environmental Equipment Co. Vaccine Safety Solutions Revenue and Gross Margin (2021-2026)
  59. 8.10.4 So-Low Environmental Equipment Co. Vaccine Safety Solutions Product Portfolio
  60. 8.10.5 So-Low Environmental Equipment Co. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst